Schwarz and Alviva in CNS development

Schwarz (Monheim, Germany) obtained access to a group of compounds from Alviva (Saskatoon, Saskatchewan) to address neurodegenerative diseases such as Parkinson's, Alzheimer's, Huntingdon's and Amyotr...